Physician profile
Krishna Vasant
NPI 1841338480
$891.26
in general payments reported to CMS, 2019-2025
8 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.13 · 2020: $18.48 · 2021: $71.35 · 2022: $59.13 · 2023: $122 · 2024: $412 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $645.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $645.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $362.20 | 2023-2024 | Watchman Access System, Wavewriter Alpha Prime 16 |
| Merck Sharp & Dohme LLC | $205.60 | 2020-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Glaxosmithkline, LLC. | $141.85 | 2019-2025 | Penmenvy |
| Genzyme Corporation | $81.26 | 2023-2024 | |
| Sanofi Pasteur INC. | $33.57 | 2019-2022 | |
| Optinose US, INC. | $28.33 | 2024 | |
| Seqirus USA INC | $20.00 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $18.45 | 2025 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishna Vasant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.